Discover 3,561 paid clinical trials in Costa Mesa, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,561
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Duarte CA, Los Angeles CA, Denver CO, Portland OR,
Sponsor: Vironexis Biotherapeutics Inc.
Sex: All
Age: 13 - 70+
Code: NCT06533579
Phase1, Phase2, Recruiting
Cryoablation of Small Breast Tumors in Early Stage Breast Cancer
for
Breast Cancer
Location: Duarte CA, Beverly Hills CA, Scottsdale AZ,
Sponsor: Sanarus Technologies, Inc.
Sex: Female
Age: 50+
Code: NCT01992250
Recruiting
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Duarte CA, Phoenix AZ, Calgary, Omaha NE, Houston TX,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06121843
Phase1, Recruiting
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
for
Coronary Artery Disease,
Location: Loma Linda CA, Thousand Oaks CA, Sacramento CA,
Sponsor: Supira Medical
Sex: All
Age: 18 - 70+
Code: NCT07296744
Recruiting
Individualized AML Treatment
for
Relapsed/Refractory Acute Myeloid Leukemia (AML)
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07613385
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
for
Advanced Solid Tumors, HER2 Mutation
Location: Duarte CA, Houston TX, Nashville TN, Cleveland OH,
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT06760819
Phase2, Recruiting
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Duarte CA, Salt Lake City UT, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05886036
Phase2, Recruiting
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma
Location: Duarte CA, Salt Lake City UT, Houston TX, Cleveland OH,
Sponsor: Karyopharm Therapeutics Inc
Sex: All
Age: 18+
Code: NCT05980806
Phase2, Recruiting
A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma
for
Solid Tumor, Adult Lymphoma
Location: Duarte CA, Houston TX, Pittsburgh PA
Sponsor: Cyclacel Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05358379
Phase1, Phase2, Recruiting
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
for
Follicular Helper T-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07278856
Phase1, Recruiting
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
for
Waldenstrom Macroglobulinemia
Location: Duarte CA, Glendale CA, Rancho Mirage CA, Las Vegas NV,
Sponsor: BeiGene
Sex: All
Age: 18+
Code: NCT05640102
Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Los Angeles CA, Scottsdale AZ, West Valley City UT,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07383506
Phase1, Recruiting
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Duarte CA, Sacramento CA, New Lenox IL, Orland Park IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05272384
Phase1, Recruiting
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: Duarte CA, Houston TX, Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT03113643
Phase1, Recruiting
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration